Tioma Therapeutics' Series A Round

Tioma Therapeutics raised a round of funding on August 07, 2015.

Tioma Therapeutics, formerly Vasculox, is a biopharmaceutical company developing anti-CD47 antibodies for the treatment of solid and hematologic cancers.…

Articles about Tioma Therapeutics' Series A Round: